ADELMAN BURT A

EVP, Development at BIOGEN INC. · on record since May 6, 2004
EVP - Research & Development at BIOGEN IDEC MA INC · on record since Nov 4, 2003
CMO & EVP, R&D at DYAX CORP · on record since Apr 1, 2013
Director at Verve Therapeutics, Inc. · on record since Jun 16, 2021
10% owner at Verve Therapeutics, Inc. · on record since Jun 16, 2021
Director at Astria Therapeutics, Inc. · on record since Apr 7, 2016

Insider trading activity of ADELMAN BURT A

Transactions on record: 241; since Sep 26, 2003

Open-market buys: 3; $354.3K

Open-market sells: 110; $33.3M

Companies traded: 5; last filing Jul 28, 2025

Figures computed from official regulatory filings — .

Companies where ADELMAN BURT A has traded

Verve Therapeutics, Inc.17 tx · $354.3K · Jul 28, 2025
Astria Therapeutics, Inc.5 tx · Jun 12, 2020
DYAX CORP30 tx · $2.6M · Jan 22, 2016
BIOGEN INC.182 tx · $51.3M · Feb 14, 2008
BIOGEN IDEC MA INC7 tx · $421.3K · Nov 4, 2003

Track record of ADELMAN BURT A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of ADELMAN BURT A

Co-insiders of ADELMAN BURT A

Ashe Andrew D.DYAX CORP +1

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-42,200	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-136,139	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-43,198	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	Other	-428,326	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 6, 2025	AwardD (derivative)	42,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 28, 2024	AwardD (derivative)	136,139	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	37,168	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	-266,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	106,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	266,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	-106,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	-37,168	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 20, 2023	AwardD (derivative)	26,642	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 13, 2022	AwardD (derivative)	15,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	May 13, 2022	Buy	10,000	12.15 USD	$121.5K	conv 58	SEC
Verve Therapeutics, Inc.Listing unverified	Mar 17, 2022	Buy	4,000	21.38 USD	$85.5K	conv 56	SEC
Verve Therapeutics, Inc.Listing unverified	Dec 6, 2021	Buy	4,700	31.34 USD	$147.3K	conv 58First in 12mo	SEC
Astria Therapeutics, Inc.Listing unverified	Jun 12, 2020	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Jun 5, 2019	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Jun 7, 2018	AwardD (derivative)	14,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Jul 28, 2017	AwardD (derivative)	6,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Apr 7, 2016	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYAX CORPListing unverified	Jan 22, 2016	Other	-208,602	—	n/a (No price was disclosed in the filing)		SEC
DYAX CORPListing unverified	Jan 22, 2016	OtherD (derivative)	-500,000	—	n/a (No price was disclosed in the filing)		SEC
DYAX CORPListing unverified	Jan 22, 2016	OtherD (derivative)	-68,542	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-42,200	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-136,139	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	OtherD (derivative)	-43,198	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jul 28, 2025	Other	-428,326	—	n/a (No price was disclosed in the filing)		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 6, 2025	AwardD (derivative)	42,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 28, 2024	AwardD (derivative)	136,139	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	37,168	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	-266,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	106,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	266,258	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	-106,200	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Feb 9, 2024	Gift	-37,168	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 20, 2023	AwardD (derivative)	26,642	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	Jun 13, 2022	AwardD (derivative)	15,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Verve Therapeutics, Inc.Listing unverified	May 13, 2022	Buy	10,000	12.15 USD	$121.5K	conv 58	SEC
Verve Therapeutics, Inc.Listing unverified	Mar 17, 2022	Buy	4,000	21.38 USD	$85.5K	conv 56	SEC
Verve Therapeutics, Inc.Listing unverified	Dec 6, 2021	Buy	4,700	31.34 USD	$147.3K	conv 58First in 12mo	SEC
Astria Therapeutics, Inc.Listing unverified	Jun 12, 2020	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Jun 5, 2019	AwardD (derivative)	7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Jun 7, 2018	AwardD (derivative)	14,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Jul 28, 2017	AwardD (derivative)	6,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Astria Therapeutics, Inc.Listing unverified	Apr 7, 2016	AwardD (derivative)	13,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
DYAX CORPListing unverified	Jan 22, 2016	Other	-208,602	—	n/a (No price was disclosed in the filing)		SEC
DYAX CORPListing unverified	Jan 22, 2016	OtherD (derivative)	-500,000	—	n/a (No price was disclosed in the filing)		SEC
DYAX CORPListing unverified	Jan 22, 2016	OtherD (derivative)	-68,542	—	n/a (No price was disclosed in the filing)		SEC